Panchsheel Organics Limited

PANCHSHEEL

INE316G01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:41:18 07/06/2024 pm IST			5-day change	1st Jan Change
180.1 ^INR	-3.25%		-5.85%	-8.11%

29/05	Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
29/05	Panchsheel Organics Limited Recommends Final Dividend	CI

Panchsheel Organics Limited Announces the Appointment of Hitesh Singh Parihar as Company Secretary and Compliance Officer

April 29, 2023 at 02:13 pm IST

Panchsheel Organics Limited announced the appointment of Mr. Hitesh Singh Parihar as Company Secretary and Compliance Officer with effect from April 28, 2023. Mr. Hitesh Singh is a qualified company secretary and a law graduate and having work experience as a company secretary more than 2 years.

Latest news about Panchsheel Organics Limited

Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	29/05	CI
Panchsheel Organics Limited Recommends Final Dividend	29/05	CI
Panchsheel Organics Limited Appoints Sonia Verma as Company Secretary and Compliance Officer	21/05	CI
Panchsheel Organics Limited Announces Resignation of Hitesh Singh Parihar as Company Secretary & Compliance Officer	29/03	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 13, 2024	14/02	CI
Panchsheel Organics Names CFO	14/02	MT
Panchsheel Organics Limited Announces CFO Changes	13/02	CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02	CI
Panchscheel Organics Board Declares Interim Dividend for Fiscal 2024	21/11	MT
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 10, 2023	10/11	CI
Panchsheel Organics Limited Approves Dividend	16/23/16	CI
Panchsheel Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Panchsheel Organics Limited Recommends Final Dividend for the Financial Year 2022-23	30/23/30	CI
Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	30/23/30	CI
Panchsheel Organics Limited Announces the Appointment of Hitesh Singh Parihar as Company Secretary and Compliance Officer	29/23/29	CI
Panchsheel Organics Limited Announces the Appointment of Gaurang Natavar Patel as Chief Financial Officer	29/23/29	CI
Panchsheel Organics Limited Announces Demise of Chandrakant Shah, Chief Financial Officer	10/23/10	CI
Panchsheel Organics Limited Declares Interim Dividend for the Year Ending March 31, 2023, Payable on or Before March 14, 2023	13/23/13	CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Panchsheel Organics Limited Announces Resignation of Nikhil Borana as Company Secretary & Compliance Officer	04/23/04	CI
Panchsheel Organics Secures Land for Fermentation Facility in Indore, India	23/22/23	MT
Panchsheel Organics Limited Receives Allotment of Land in DMIC Vikram Udyogpuri Biotech Park Near Indore	23/22/23	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 14, 2022	14/22/14	CI
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI

Chart Panchsheel Organics Limited

Duration

Period

More charts

Company Profile

Panchsheel Organics Limited is an India-based company engaged in manufacturing and exporting active pharmaceutical ingredients (APIs), intermediates and finished formulations (both human and veterinary). Its specialties include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression granules, fitness and healthcare, and product development and testing laboratory. The Company offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone, Leflunomide, and others. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and others. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder, Phytosterol, and others.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PANCHSHEEL ORGANICS LIMITED	-8.11%	29.37M
ELI LILLY AND COMPANY	+43.64%	754B
NOVO NORDISK A/S	+41.00%	630B
JOHNSON & JOHNSON	-6.58%	352B
MERCK & CO., INC.	+19.72%	331B
ABBVIE INC.	+8.78%	298B
ASTRAZENECA PLC	+18.65%	250B
NOVARTIS AG	+12.21%	217B
ROCHE HOLDING AG	-0.45%	216B
AMGEN INC.	+6.13%	164B